and to think there are clowns here thinking its a great buy! This stock could be cut in half and it would still be overvalued.
Sentiment: Strong Sell
well its Thursday and still no $72-let alone $77 mr. chartypants, lol!
Try a little fundy analysis --you might realize that p/e's of 280 are not sustainable.
Sentiment: Strong Sell
No insider selling in over a month...and that was just routine stuff. It might be possible that you are short and expect that we are going to sell based on your ridiculous statement. And all this talk of after hours - equally ridiculous. Just traders clearing out trades after hours - happens all the time. You have to watch the volume. Unless the market tanks, this will open at $70.80 and bolt to $72 on Tuesday. We just retested the short-term lows (back and fill) and now it is upward toward $77 before the next downdraft. This stock is heading toward the mid-$90's this spring. Perfect chart.
I will take a shot at this. Its called Option expiration. Now this doesn't trade a lot of option but hey if you can pull this one down and screw the calls above why not. Most of the open interest is at 60 so they also just lost 500.00 x 800 OI = $400,000. I'd say some Jr. exec. just earned a nice bonus for staying after the bell. Remember options close today Sat. not Friday close We see monday open. could be a nice buy op.
AH prices can get pretty Freaky and return to normal on the next trading day , hope this is one of those times . Shows the same drop in Yahoo , CNN Money and Nasdaq .
quote says stock is down 4.51 and then I think oh boy I need to buy a few more shares and Scottrade is telling me the price ask is: 74.87 Does anyone know the real price? dah dum dungies
Good point... See SRPT board.. A tiny stock with the most active board.....Mostly pumpers, but a few realists fighting it out everyday for years...
I'm here and I hear you. This company has some formidable products in their pipeline.
They have an understanding of the opiate system in the CNS. They also did the impossible - made a form of olanzapine without weight gain.
But Rodney was great and so is this stock. Probably speaking to myself here. Echo! Echo echo......
Sentiment: Strong Buy
See 5/6/14 IOS Press - Google "Exenatide Parkinson's IOS" and Google "Exanetide Alzheimer's"
No recent updates- but what is ALKS royalty on Bydureon? (Bydureon = Exanetide)
From IOS- A follow-up study of patients with Parkinson’s disease (PD) who participated in an earlier “proof of concept” clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy. These data provide strong encouragement for the further study
A follow-up study of patients with Parkinson’s disease (PD) who participated in an earlier “proof of concept” clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy. These data provide strong encouragement for the further study of this drug in patients with PD, report researchers in the Journal of Parkinson’s Disease.
Several recent discoveries have highlighted common cellular pathways that potentially relate neurodegenerative processes with abnormal mitochondrial function and abnormal glucose metabolism.
Exenatide, a glucagon-like peptide-1 agonist (GLP-1 agonist) medication marketed as Byetta® and Bydureon® and used in the treatment of insulin resistance in patients with Type 2 diabetes, has been proposed as a disease modifying drug in PD